Patent · US Active

Biological self-assembled nanocrystal injection having a lymphatic targeting function and preparation method

US12171864B2 · kind B2 · utility

0Cited by

1References

12Claims

0Family size

Assignee

SHENZHEN CHINA RESOURCES JIUCHUANG MEDICAL AND PHARMACEUTICAL CO., LTD · CN

Inventors

Jun Liu · Dressendorf, DE
Tiantian Ye · 东风镇, CN
Dan Zhang · San Diego, US

Key dates

Filing date	Sep 15, 2017
Grant date	Dec 24, 2024
Priority date	—
Expiry date	Jan 24, 2040

Classification

Technology area (CPC B)Performing Operations; Transporting
CPC primaryB82Y5/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A biological self-assembled nanocrystal injection having a lymphatic targeting function and an administration method for targeting a lymphatic system using the biological self-assembled nanocrystal injection. The injection comprises 0.05-5% of mitoxantrone and a salt thereof, 0.1-10% of an osmotic pressure regulator, 0.001-0.1% of a buffering agent, 0.01-0.1% of an antioxidant, 0.05-1% of an adsorbent, and 0-20% of a filler. The administration method is interstitial injection, and a lymph node will produce a blue color visible to the naked eye after passive targeting to the lymphatic system.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.